ADNP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.731400E-01
Normal-vs-Stage2
3.003200E-01
Normal-vs-Stage3
5.151900E-02
Normal-vs-Stage4
9.583800E-01
Stage1-vs-Stage2
9.792600E-01
Stage1-vs-Stage3
4.481500E-02
Stage1-vs-Stage4
2.534200E-01
Stage2-vs-Stage3
3.001700E-02
Stage2-vs-Stage4
1.999000E-01
Stage3-vs-Stage4
1.756400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.368200E-01
Normal-vs-AfricanAmerican
9.336600E-01
Normal-vs-Asian
1.715620E-01
Caucasian-vs-AfricanAmerican
2.369000E-01
Caucasian-vs-Asian
1.867600E-01
AfricanAmerican-vs-Asian
1.048580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.957800E-01
Normal-vs-Female
2.954000E-01
Male-vs-Female
8.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.529400E-01
Normal-vs-Age(41-60Yrs)
6.450200E-01
Normal-vs-Age(61-80Yrs)
2.679800E-01
Normal-vs-Age(81-100Yrs)
2.084800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.887000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.223020E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.100800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.423000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.328400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.170220E-01
Normal-vs-Daily Drinker
2.739000E-01
Normal-vs-Weekly Drinker
2.174400E-01
Normal-vs-Occasional Drinker
7.590000E-01
Normal-vs-Social Drinker
7.785600E-01
Non Drinker-vs-Daily Drinker
5.877000E-01
Non Drinker-vs-Weekly Drinker
7.400000E-01
Non Drinker-vs-Occasional Drinker
1.321840E-02
Non Drinker-vs-Social Drinker
2.976200E-02
Daily Drinker-vs-Weekly Drinker
8.843600E-01
Daily Drinker-vs-Occasional Drinker
9.290400E-02
Daily Drinker-vs-Social Drinker
1.436410E-01
Weekly Drinker-vs-Occasional Drinker
8.034100E-02
Weekly Drinker-vs-Social Drinker
1.316830E-01
Occasional Drinker-vs-Social Drinker
9.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.359800E-01
Normal-vs-Grade 2
5.355900E-02
Normal-vs-Grade 3
3.554500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.366400E-01
Grade 1-vs-Grade 3
3.431000E-01
Grade 1-vs-Grade 4
2.359800E-01
Grade 2-vs-Grade 3
3.554400E-02
Grade 2-vs-Grade 4
5.355900E-02
Grade 3-vs-Grade 4
3.554500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.591230E-01
Normal-vs-NonDiabetic
3.428600E-01
Diabetic-vs-NonDiabetic
2.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.376200E-01
Normal-vs-NoPancreatitis
3.129400E-01
Pancreatitis-vs-NoPancreatitis
7.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.124600E-01
Normal-vs-N1
3.225600E-01
N0-vs-N1
8.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.551000E-01
Normal-vs-TP53-NonMutant
6.454200E-01
TP53-Mutant-vs-TP53-NonMutant
4.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
